Finance

Lists
STTK:NASDAQ
Shattuck Labs Inc
$7.25
-5.35%
(-0.41) 1D
$7.25
0.00% (0.00)
After hours
Closed: Aug 20, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STTK...
Open
$7.56
High
$7.56
Low
$7.24
Mkt. cap
727.63M
Avg. vol.
1.14M
Volume
416.30K
52-wk high
$8.33
52-wk low
$0.79
EPS
-$0.51
Beta
1.09
Shares outstanding
100.36M
No. of employees
40
Open
$7.56
High
$7.56
Low
$7.24
Mkt. cap
727.63M
Avg. vol.
1.14M
Volume
416.30K
52-wk high
$8.33
52-wk low
$0.79
EPS
-$0.51
Beta
1.09
Shares outstanding
100.36M
No. of employees
40
News stories
From web sources and news partners
About Shattuck Labs Inc
CEO-
Employees40
Founded2016
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websiteshattucklabs.com
Analyst ratings
Based on 5 analysts giving stock ratings to STTK in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for STTK in the last 3 months.
Highest
Current $7.25
$18.00 (+148.28%)
Average
$14.60 (+101.38%)
Lowest
$11.00 (+51.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Buy
Maintained
$13.00
+79.3%
08/12/2026
David Nierengarten
Wedbush
Buy
Maintained
$11.00
+51.7%
08/12/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$18.00
+148.3%
08/12/2026
Joseph Stringer
Needham
Buy
Maintained
$17.00
+134.5%
08/11/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$14.00
+93.1%
08/12/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/07/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
04/27/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$15.00
+106.9%
04/13/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.12 / -$0.12
+2.84%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.00M
-
-
-
Cost of goods sold
7.62M
8.97M
10.95M
11.70M
Cost of revenue
7.62M
8.97M
10.95M
11.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.10M
4.32M
4.60M
4.46M
Operating expense
4.10M
4.32M
4.60M
4.46M
Total operating expenses
11.72M
13.29M
15.54M
16.16M
Operating income
-10.72M
-13.29M
-15.54M
-16.16M
Other non operating income
660.00K
-1.92M
-1.00K
-26.00K
EBT including unusual items
-10.06M
-12.59M
-14.77M
-15.15M
EBT excluding unusual items
-10.06M
-12.51M
-14.77M
-15.15M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.06M
-12.59M
-14.77M
-15.15M
Net profit margin
-1,005.60%
-
-
-
Earnings per share
-0.14
-0.12
-0.13
-0.12
Interest and investment income
-
2.70M
779.00K
1.03M
Interest expense
-
-
-
-
Net interest expenses
-
2.70M
779.00K
1.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.80M
-12.38M
-14.65M
-15.30M
Gain or loss from assets sale
47.00K
-47.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps